Citations(0)

Content

How to Cite This Article

Download Download [ PDF ]

Email Send to a friend

Page Views Page Views(310)

Facebook ShareFacebook Share

Twitter ShareTwitter Share

Year : 2017 Month : March Volume : 6 Issue : 25 Page : 2061-2064

ASSOCIATION OF SERUM PROLACTIN WITH INFERTILITY.

Lakshmi G1, Sheela Balakrishnan2, Syamsundar O. S3

1Associate Professor, Department of Physiology, Government Medical College, Trivandrum.
2Professor, Department of Obstetrics and Gynaecology, Government Medical College, Trivandrum.
3Physician, General Hospital, Trivandrum.

CORRESPONDING AUTHOR

Dr. Lakshmi G,
Email : Lakshmi.syam92@gmail.com

ABSTRACT

Corresponding Author:
Dr. Lakshmi G,
Associate Professor,
Department of Physiology,
Government Medical College,
Trivandrum.
E-mail:lakshmi.syam92@gmail.com

ABSTRACT

BACKGROUND

Hyperprolactinaemia was found to be an important cause of infertility in early seventies. Despite adequate release of gonadotropic hormones, in the presence of hyperprolactinaemia, ovulation fails to occur. Suppression of prolactin concentration to normal led to resumption of normal menstrual pattern.

The aim of this study was to find out the association between serum prolactin and infertility in females of reproductive age group.

Materials and methods

In this prospective study, fifty females of reproductive age group with irregular periods were selected as cases; control group comprised fifty females of reproductive age group with regular periods. The parameters studied were body mass index, recent weight gain, dysmenorrhoea, dyspareunia, hirsutism, galactorrhoea and serum prolactin. Estimation of serum prolactin was done using Coat-A-Count prolactin IRMA, an immunoradiometric assay designed for the quantitative measurement of prolactin in serum. statistical analysis done using Pearson Chi square test.

Settings and Design- Prospective longitudinal study.

Results

Cases with BMI greater than 25 were 38%, recent weight gain 42%, hirsutism 38%, dysmenorrhoea 84%, dyspareunia 24%, galactorrhoea 12%. 22% cases show higher prolactin levels, out of these 12% only presented with galactorrhoea.

Conclusion

Serum prolactin has a definite role in infertility.

Keywords

pregnancy, serum prolactin, infertility, galactorrhoea, dysmenorrhoea, dyspareunia.

BACKGROUND

In any community, mothers and children constitute a priority group in India, women of the child bearing age (15-44 years) constitute 19%. With the advent of modern techniques and treatment strategies, we have now revealed many a cause of infertility and this information is leading us to quite unknown fields where the treasures lay in the depth to be explored. Though the problem of infertility remained quite ignored, it definitely imparts a social stigma and a constant mental agony to the couple concerned.

There are many factors that may cause increasing infertility. Even under ideal conditions, the probability that a woman will get pregnant during a single menstrual cycle is only 30%, but even when conception does occur, only 50-60% pregnancy advances beyond 20th week. Among the female causes of infertility, 59% is contributed by ovarian dysfunction.1

Hyperprolactinaemia was found to be an important cause of infertility in early seventies. Early changes of serum prolactin level could lead to subtle changes in ovulation which might have profound effects on infertility, but abnormal levels of serum prolactin relate largely to changes in ovulation. Changes in serum prolactin level produce menstrual irregularities and problems related to reproductive function is not a new development.

There is a direct impact of serum prolactin level on luteal function of the ovary. High concentrations of prolactin was associated with normal or low blood concentration of luteinising hormone or follicle stimulating hormone and adequate release In response to gonadotropic releasing hormone (Thorner et al, 1974). High concentration of prolactin while closely associated with ovarian activity might not act directly on the ovary and maintenance of ovarian function by exogenous gonadotropins might overcome any direct inhibitory effect of prolactin on gonads. In vitro, high concentration of prolactin equivalent to those seen in lactation, inhibit progesterone production by human granulosa cells even in the presence of high FSH and LH. (McNatty et al 1974).2 In the presence of high prolactin levels, blood concentrations of FSH are high normal and of LH low normal without pulsatile secretion and there is absence of ovarian activity as judged by an absence of oestrogen secretion. Despite adequate release of FSH and LH3 in the pituitary, oestrogen fails to induce a positive feedback release of LH and hypothalamus-pituitary axis appear more sensitive to the negative feedback effect of oestrogen. Suppression of prolactin concentration to normal led to the resumption of normal menstrual cycle. (Rolland et al 1975. Glass et al 1975).4,5 Hence the study was undertaken with the hope that incidence of infertility may be reduced by proper monitoring of the serum prolactin level. Any defect of the prolactin level may be treated so that we will be more confident in reducing the chance of infertility through this approach.

How serum prolactin levels affect the fertility of a woman? This is a question to be answered in the present scenario. Infertility is a complex medical, social and individual problem but nothing is known about the risk factors and their mechanism of action in the study of reduced fertility. This was what inspired us to probe into this topic.

 

MATERIALS AND METHODS

Fifty female patients of reproductive age group with irregular periods attending the infertility clinic in SAT Hospital, Thiruvananthapuram were selected as the study group. The control group comprised of fifty patients selected from females of reproductive age group with regular periods. Among the cases were females of reproductive age group not conceiving after one year of unrestricted intercourse with no abnormality detected in their partners and females having infertility with irregular periods. Those with generalised illness, endocrine disorders, congenital abnormalities of female genital tract were excluded from the study. Parameters studied were body mass index, recent weight gain, dysmenorrhoea, dyspareunia, hirsutism, galactorrhoea and serum prolactin. Estimation of serum prolactin was done using Coat-A-Count prolactin IRMA, an immunoradiometric assay designed for the quantitative measurement of prolactin in serum.

 

Statistical Analysis

For the entry of the statistical data, the computer package used was Microsoft excel. For analysis, SPSS of windows Version 10 was used. P value of <0.01 was considered highly significant, P value of <0.05 was considered significant, P value of >0.05 was not considered to be significant statistically. Association among variables was assessed using Pearson chi square test.

 

RESULTS

38% among the case group shows values of body mass index greater than 25 whereas only 12% among the control group shows values greater than 25. 80% of the control group and 50% of the case group had body mass index within the normal range (Table 1). 42% of the cases show recent weight gain whereas none among controls show recent weight gain. (Table 2). Hirsutism is present in 38% of cases whereas none among the controls show hirsutism.

84% of the patients among the case group presented with dysmenorrhoea whereas only 18 among the control group presented with the same symptom. 82% among the control group showed no symptom of dysmenorrhoea, so the association of dysmenorrhoea and infertility was found to be statistically very highly significant. (Table 3). 24% among the cases presented with dyspareunia whereas none among the control group presented with dyspareunia. (Figure 1).

12% among the cases presented with galactorrhoea and 88% among the cases did not present with galactorrhoea. Since none among the control group presented with galactorrhoea, the association of galactorrhoea and infertility was found to be statistically highly significant. (Table 4).

78% among the cases showed normal prolactin levels whereas 22% were with prolactin levels greater than 25 ng/mL. Out of these 22%, only 12% cases presented with galactorrhoea. So, all patients with raised prolactin levels need not present with galactorrhoea. None among the controls showed raised prolactin levels. (Figure 1).

 

BMI

(Kg/m2)

Group

Cases

Control

<18

6

12.0 %

4

8.0%

18-25

25

50.0%

40

80.0%

>25

19

38.0%

6

12.0%

Table 1. BMI

 

Chi square test Value P. Value Highly Significant.

With Yates correction 10.622, 0.005.

 

Dysmenorrhoea

Group

Cases

Control

No

8

16.0 %

41

82.0%

Yes

42

84.0%

9

18.0%

Table 2. Dysmenorrhoea

 

Chi square test Value P. Value Very Highly Significant.

With Yates correction 43.577, 0.000.

 

Dyspareunia

Group

Cases

Control

No

38

76.0 %

50

100.0%

Yes

12

24.0%

0

Table 3. Dyspareunia

 

Chi square test Value P. Value Very Highly Significant.

With Yates correction 13.636, 0.000.

 

Hirsutism

Group

Cases

Control

No

30

60.0 %

50

100.0%

Yes

19

38.0%

0

Table 4. Hirsutism

 

Chi square test Value P. Value Very Highly Significant

With Yates correction 25.0, 0.000

 

Prolactin

Group

Cases

Control

Normal

(5-25 ng/mL)

39

78.0 %

50

100.0%

Raised

(>25 ng/mL)

19

22%

0

Table 5. Prolactin

 

 

Chi square test Value P. Value Highly Significant.

With Yates correction 12.360, 0.000.

DISCUSSION

As per Table 1, 38% of the cases with BMI greater than 25 kg/m2 are more prone to obesity. Most of the infertile patients are obese. In obesity, there is peripheral conversion of androgen to oestrogen by the enzyme aromatase in the adipose tissue stromal cells. The greater the obesity, the more will be the peripheral aromatisation of androgens to oestrogens especially oestrone. The high concentration of oestrone sensitises the pituitary to secrete excessive androstenedione, which perpetuates the vicious cycle of androgen to oestrone. Anovulation is because of the disturbance in the dynamics of androgen-oestrogen conversion. There is altered feedback regulation of cyclic gonadotropin release because of the constant outpouring of oestrogen from extraovarian sources. (oestrone hypothesis of Asharmasya et al 1999). 6

Oestrogen appears in three forms in circulation-oestradiol, oestrone, oestriol. LH surge leading to ovulation can occur only in the presence of excess oestradiol in the serum. Oestrone levels increased due to peripheral conversion of androgens in extraovarian sources. This exerts a negative feedback effect on the secretion of FSH from anterior pituitary. Low FSH level can impair the production of oestradiol in ovary.7 Low FSH levels impair granulosa cell growth and inhibits aromatase enzyme essential for conversion of androgen to oestrogen (Short and London 1961).8,9 More and more androgens enter the circulation. But there may be decreased concentration of sex hormone binding globulin due to decreased levels of thyroid hormones. So androgens in the circulation remain as free androgens resulting in hirsutism.10 This is indicated by the results of analysis as per Figure 1, which shows 38% cases with hirsutism. This androgen excess is reversible with weight loss.

Regarding the relationship of dysmenorrhoea with infertility, there is a strong supportive correlation as evidenced by the occurrence of dysmenorrhoea in 84% cases in this study. Dysmenorrhoea is due to uterine smooth muscle contraction induced by increased levels of prostaglandins in menstrual fluid by secretory endometrium.11 Dysmenorrhoea is usually associated with ovulatory cycles. The occurrence of dysmenorrhoea is associated with the release of PGF2α from the endometrium. Synthesis of PGF2α is dependent on oestrogen and progesterone production which definitely occurs only after ovulation. in anovulatory cycles,12 there is increased oestrogen unopposed by progesterone which causes a hyperplastic or proliferative endometrium with a reduced capacity to synthesise PGF2α. This explains the absence of painful menses in 16% of cases. But there are evidences that prostaglandin is also released from adipose tissue in response to nerve stimulation and catecholamine administration. So dysmenorrhoea may be common in women with high body mass index and infertility.13,14

Results of analysis as per Table 4, Figure 2, shows a positive correlation between hyperprolactinaemia, galactorrhoea and infertility. Prolactin synthesis and release from the lactotrophs are controlled by neurotransmitters which act on the pituitary via hypothalamus. The main control mechanism is inhibition by dopamine which acts on the pituitary. Although prolactin releasing factor has not been isolated it is known that thyrotropin releasing factor stimulates prolactin release.14

One of the mechanisms by which elevated prolactin levels cause ovulatory dysfunction is by stimulating the production of dopamine in hypothalamus. Dopamine can inhibit GnRH release by norepinephrine secretion. Decreased GnRH leads to a decrease in the pituitary FSH and LH. A decrease in the FSH and LH is the basis of most prolactin based ovulatory problem.15

Prolactin can also decrease progesterone production by granulosa cells when grown in culture. This can also lead to luteal phase defect and anovulation.16,17

Another mechanism has been put forward for the cause for ovulatory dysfunction associated with raised prolactin levels. Hyperprolactinaemia can cause alteration in GnRH release not synthesis.18 Alteration in GnRH release cause abnormalities in the frequency and amplitude of gonadotropins especially LH pulsations. Alterations in LH pulsations can affect ovulation. Thus, elevated levels of prolactin directly inhibit basal as well as gonadotropin stimulated ovarian secretion of oestrogen and progesterone, which can cause ovulatory dysfunction.19,20

In addition, there are prolactin receptors on the adrenal gland. The adrenal glands respond by an increase in their own androgenic hormones which can also interfere with ovulation.21,22

In the presence of hyperprolactinaemia, despite adequate releasable LH and FSH in the pituitary, oestrogen fails to induce a positive feedback release of LH and ovulation will not occur. Suppression of prolactin concentration led to resumption of normal menstrual cycle and ovulation.23

The observation in the present study points to the fact that a closely intertwined relationship exists between serum prolactin and infertility. Ideally complete followup of all patients attending the infertility clinic should be done which is not possible during the short span of the study. Hope this study is successful in the explanation of pituitary–ovary relation and add to the practical knowledge of human reproduction. It is our hope that the future workers in this field would be benefitted with more insights into the enigma that serum prolactin continues to alleviate the anguish of the couples concerned and those in the medical profession alike.

CONCLUSION

The present study supports the possible role of serum prolactin in infertility. In addition, Body Mass index, dysmenorrhoea, dyspareunia play a vital role in infertility. So, appropriate screening of all infertile patients is recommended, routinely to evaluate pituitary function by prolactin estimation. Associated obesity, hirsutism, dysmenorrhoea, dyspareunia should be investigated. The screening and treatment of these patients should be continued even after conception. This might help in the early initiation of corrective measures that prevent or limit the damage to mother and foetus. Hope this study may throw light for all the couples concerned who seek treatment for infertility.

Limitations of the Study

The study was of short duration. Proper followup of the patients was not done.

Videos :

watch?v